Status:
COMPLETED
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized clinical trial (RCT) of 300 persons with serious mental illness (SMI) and medical comorbidity will evaluate outcomes for n=100 in a Community Based Health Home alone (CBHH), compared t...
Detailed Description
Efforts to reduce early mortality in persons with serious mental illness (SMI) have largely focused on providing integrated primary care in a "health home". Yet medical care alone accounts for a dispr...
Eligibility Criteria
Inclusion
- Age 18 or older and enrolled in treatment for at least 3 months;
- SMI as defined by (i) primary DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) Axis I diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or major depressive disorder; (ii) moderate impairment across multiple areas of psychosocial functioning, including social relationships, self-care, community/work activity, treatment self-management, and community living skills; (iii) GAF (Global Assessment of Functioning) score less than 61. The broad range of SMI are included primarily because findings will be more generalizable to routine mental health settings, but also because we included this group in our pilot studies;
- Diagnosis of one of the following medical illnesses or health conditions: diabetes, heart disease, chronic obstructive pulmonary disease, chronic pain, hyperlipidemia, hypertension, obesity, tobacco dependence;
- Voluntary informed consent for participation in the study by the participant or by the participant's legally designated guardian;
- An expressed willingness to participate in self-management training or a telehealth program;
- Ability to read the telehealth display in English.
Exclusion
- Currently residing in a nursing home or group home;
- Terminal physical illness expected to result in the death of the study subject within 12-24 months; or
- Primary diagnosis of dementia, co-morbid diagnosis of dementia, or significant cognitive impairment as indicated by a Mini Mental State Examination (MMSE)74 score \<24.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
301 Patients enrolled
Trial Details
Trial ID
NCT02188732
Start Date
January 1 2015
End Date
July 31 2021
Last Update
August 27 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Bay Cove Human Services
Boston, Massachusetts, United States, 02114
2
Vinfen
Cambridge, Massachusetts, United States, 02141-1001